754 related articles for article (PubMed ID: 22996250)
1. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
[TBL] [Abstract][Full Text] [Related]
2. Hepatic hemangioendothelioma: CT, MR, and FDG-PET-CT in 67 patients-a bi-institutional comprehensive cancer center review.
Ganeshan D; Pickhardt PJ; Morani AC; Javadi S; Lubner MG; Elmohr MM; Duran C; Elsayes KM
Eur Radiol; 2020 May; 30(5):2435-2442. PubMed ID: 32002639
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
[TBL] [Abstract][Full Text] [Related]
4. CT and MR imaging findings of hepatic epithelioid hemangioendotheliomas: emphasis on single nodular type.
Kim EH; Rha SE; Lee YJ; Yoo IeR; Jung ES; Byun JY
Abdom Imaging; 2015 Mar; 40(3):500-9. PubMed ID: 25179888
[TBL] [Abstract][Full Text] [Related]
5. Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging.
Bruegel M; Muenzel D; Waldt S; Specht K; Rummeny EJ
Abdom Imaging; 2011 Aug; 36(4):415-24. PubMed ID: 20730424
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature.
Kitapci MT; Akkaş BE; Gullu I; Sokmensuer C
Ann Nucl Med; 2010 Aug; 24(7):549-53. PubMed ID: 20414751
[TBL] [Abstract][Full Text] [Related]
7. F-18 FDG PET/CT monitoring of radiation therapeutic effect in hepatic epithelioid hemangioendothelioma.
Suga K; Kawakami Y; Hiyama A; Hori K
Clin Nucl Med; 2009 Mar; 34(3):199-202. PubMed ID: 19352294
[TBL] [Abstract][Full Text] [Related]
8. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
9. Diffuse hepatic epithelioid hemangioendothelioma with multiple splenic metastasis and delayed multifocal bone metastasis after liver transplantation on FDG PET/CT images: A case report.
Tan Y; Yang X; Dong C; Xiao Z; Zhang H; Wang Y
Medicine (Baltimore); 2018 Jun; 97(22):e10728. PubMed ID: 29851777
[TBL] [Abstract][Full Text] [Related]
10. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
11. MRI of hepatic epithelioid hemangioendothelioma (HEH).
Paolantonio P; Laghi A; Vanzulli A; Grazioli L; Morana G; Ragozzino A; Colagrande S
J Magn Reson Imaging; 2014 Sep; 40(3):552-8. PubMed ID: 24677597
[TBL] [Abstract][Full Text] [Related]
12. Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
Lin E; Agoff N
Clin Nucl Med; 2007 Dec; 32(12):949-51. PubMed ID: 18030050
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
14. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
15. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma.
Lin J; Ji Y
Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):154-8. PubMed ID: 20382586
[TBL] [Abstract][Full Text] [Related]
16. Imaging characteristics and prognostic values of hepatic epithelioid hemangioendothelioma on
Wang W; Liu G; Hu P; Pang L; Gu T; Yu H; Luo R; Yang X; Shi H
Clin Exp Med; 2020 Nov; 20(4):557-567. PubMed ID: 32797371
[TBL] [Abstract][Full Text] [Related]
17. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
18. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
20. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
Cho WI; Chang UK
J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
